The Rising Impact of PCSK9 Inhibitors: Transforming Cardiovascular Treatmen...

The cardiovascular therapeutic landscape has experienced a paradigm shift with the advent of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.

• davidcracc